Viatris (VTRS) EBT Margin (2019 - 2026)
Viatris (VTRS) posted EBT Margin of 1.7% for Q2 2026, up 75.77% on a QoQ basis from 7.03% in Q1 2026, and up 436.0% year-over-year from 0.32% in Q2 2025.
Powered by 
Analysis
Viatris (VTRS) EBT Margin (2019 - 2026) Analysis & Trends
Viatris has reported EBT Margin for 8 years, with the latest figure at 1.7% in Q2 2026.
- On a quarterly basis, EBT Margin rose 436.0% year-over-year to 1.7% in Q2 2026; TTM through Jun 2026 was 4.49%, a 2207.0% increase from a year earlier, with the FY2025 full-year figure at 25.63%, down 2140.0% from the prior year.
- EBT Margin was 1.7% for Q2 2026 at Viatris, up from 7.03% in the prior quarter.
- The five-year high for EBT Margin was 37.9% in Q4 2022, with the low at 95.17% in Q1 2025.
- Average EBT Margin over 5 years is 3.4%, with a median of 1.1% recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 10075 bps in 2025, then soared 8813 bps in 2026.
- Over 5 years, EBT Margin stood at 37.9% in 2022, then plunged by 159 bps to 22.28% in 2023, then surged by 33 bps to 14.92% in 2024, then soared by 38 bps to 9.26% in 2025, then soared by 82 bps to 1.7% in 2026.
- The last three EBT Margin figures came in at 1.7% (Q2 2026), 7.03% (Q1 2026), and 9.26% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -10.99% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -1.70% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.85% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 8.92% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 12.20% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -121.92% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 13.94% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 20.96% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 11.27% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.70% |
| Mar 31, 2026 | -7.03% |
| Dec 31, 2025 | -9.26% |
| Sep 30, 2025 | -0.21% |
| Jun 30, 2025 | -6.06% |
| Mar 31, 2025 | -95.17% |
| Dec 31, 2024 | -14.92% |
| Sep 30, 2024 | 2.41% |
| Jun 30, 2024 | -10.32% |
| Mar 31, 2024 | 5.58% |
| Dec 31, 2023 | -22.28% |
| Sep 30, 2023 | 10.20% |
| Jun 30, 2023 | 8.50% |
| Mar 31, 2023 | 8.65% |
| Dec 31, 2022 | 37.90% |
| Sep 30, 2022 | 10.48% |
| Jun 30, 2022 | 9.46% |
| Mar 31, 2022 | 12.58% |
| Dec 31, 2021 | -4.70% |
| Sep 30, 2021 | 4.41% |